Bio*One Capital's A-Bio Pharma Secures A Second Deal With GlaxoSmithKline
$9 million Expansion of Facility Underway
This deal follows the first project with GSK Bio that was announced in November 2004 as well as the master service agreement with Novo Nordisk A/S in May 2005.
With the securing of these agreements as well as a few more in the pipeline, there will be a further investment of S$9 million (US$5.5 million) to expand A-Bio's cell culture manufacturing capacity to meet increasing customer demand. A-Bio will add a 500L stirred tank bioreactor to its existing 200L capacity.
Organizations
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.